SEP 05, 2017 2:24 PM PDT

"STING" Leads to T Cell Death

WRITTEN BY: Kara Marker

There are key differences between the two parts of the immune system - innate and adaptive - and a new study adds one more to the list. Cells of the respective immune responses react drastically different to a signaling pathway called STING. One response results in life, the other results in death.

T-lymphocytes within myocardium. Credit: Westgate Research Team

The STING (stimulator of interferon genes) pathway is employed by the innate immune system to detect viral DNA. Cells of the innate immune system are first-responders, detecting and targeting a pathogenic invasion, mounting a response that’s nonspecific but strong. At a certain point, the adaptive immune system takes over and delivers a more targeted response specific to the type of threat challenging the body.

Innate immune system cells use receptors to identify nucleic acids and activate STING, which then turns on a set of genes that produce cytokines, chemical messengers that promote interaction between cells, and other processes to fight pathogens.

Scientists had a clear understanding of how innate immune cells used STING, but does STING trigger the same or different responses in cells of the adaptive immune system? From Ecole Polytechnique Federale De Lausanne (EPFL), researchers found that not only is the response different in the adaptive immune system - it’s toxic.

In response to STING, adaptive immune system cells called T cells undergo apoptotic, or self-destructive, cell death. Researchers have linked this type of damage to T cell diseases like lymphoma. This happens, researchers found, because STING induces the expression of BH3-only proteins, activating apoptosis in cells instead of producing cytokines.

Researchers see this study’s findings as a wake-up call; STING can be activated in different ways to produce different responses in the immune system, and some may be detrimental to human health. They are already pursuing one method of intervention: a small molecule that activates STING to prevent growth of T cell-derived tumors.

About T cell lymphoma

Lymphoma - all types - is the most common type of blood cancer. T cell lymphoma makes up approximately ten percent of non-Hodgkin lymphomas. In T cell lymphoma, cancer can affect multiple organs, including the lymph nodes, spleen, bone marrow, and the blood.

The present study was published in the journal Nature Communications.

Sources: Lymphoma Research Foundation, Nature Reviews Immunology, Ecole Polytechnique Federale De Lausanne

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
NOV 12, 2019
Immunology
NOV 12, 2019
Allergy Shots May Work for Kids with Pollen Food Allergy Syndrome
It’s not common for young children to develop pollen food allergy syndrome (PFAS), but for those that do, there’s not too much parents can do o...
DEC 17, 2019
Immunology
DEC 17, 2019
Increased Belly Fat with Aging Linked to Reduced Mental Flexibility
Did you ever consider that your brain can flex similarly to the way your biceps can? Sure, brain flexing is more abstract and less literal, but the concept...
JAN 08, 2020
Cell & Molecular Biology
JAN 08, 2020
In a First, Scientists Generate Early Human Immune Cells in the Lab
Now we know more about the early stages of the human immune system....
FEB 21, 2020
Drug Discovery & Development
FEB 21, 2020
Why is it so Difficult to Develop a Vaccine for Coronavirus?
As of February 21st, 2,250 have died worldwide from Coronavirus, while 18,862 have recovered and 55,703 are currently infected. Having made top news storie...
MAR 20, 2020
Drug Discovery & Development
MAR 20, 2020
4 Potential Treatments for SARS-CoV-2 Currently Under Testing
Currently, no medicine nor vaccine has been approved as effective for the prevention of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Despi...
MAR 23, 2020
Drug Discovery & Development
MAR 23, 2020
Is Fast-Tracking Vaccines for Coronavirus Really Such a Good Idea?
Donald Trump has called on researchers to “slash red tape like nobody has even done it before” to accelerate the development of vaccines for th...
Loading Comments...